SORRENTO THERAPEUTICS INC generated $62.8M in revenue in fiscal year 2022. This represents an increase of 18.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to $64.3M in revenue. The table below carries 15 fiscal years, from 2008 to 2022, and the quarters SORRENTO THERAPEUTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SRNE Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
SRNE Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More SORRENTO THERAPEUTICS INC financials
Frequently Asked Questions
What was SORRENTO THERAPEUTICS INC's revenue in fiscal year 2022?
SORRENTO THERAPEUTICS INC generated $62.8M in revenue in fiscal year 2022.
How fast is SORRENTO THERAPEUTICS INC's revenue growing?
SORRENTO THERAPEUTICS INC (SRNE) revenue rose by 18.8% year over year, from $52.9M to $62.8M in fiscal year 2022.
What is SORRENTO THERAPEUTICS INC's revenue over the last twelve months?
SORRENTO THERAPEUTICS INC (SRNE) reported $64.3M in revenue over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
What was SORRENTO THERAPEUTICS INC's revenue in the most recent quarter?
SORRENTO THERAPEUTICS INC (SRNE) reported $15.0M in revenue in Q2 2023. This represents an increase of 31.1% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what SORRENTO THERAPEUTICS INC (SRNE) reported on that line in every period on record.